Vireo Growth Inc. SEC filings VREOF
Vireo Growth Inc. has 362 filings in SEC EDGAR's recent list, going back to Apr 1, 2019. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (material agreement, agreement ended, new debt, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEF 14A | Proxy statement | Apr 16, 2026 | May 29, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 6, 2026 | May 29, 2026 |
| DEFA14A | Additional proxy material | May 9, 2025 | — |
| DEF 14A | Proxy statement | May 9, 2025 | Jun 20, 2025 |
| PRE 14C | Filing | Mar 7, 2025 | Mar 7, 2025 |
| DEFA14A | Additional proxy material | May 10, 2024 | — |
| DEF 14A | Proxy statement | May 10, 2024 | Jun 21, 2024 |
| DEFA14A | Additional proxy material | Apr 17, 2024 | — |
| DEF 14A | Proxy statement | Oct 19, 2022 | Nov 18, 2022 |
| PREM14A | Filing | Jul 20, 2022 | Jul 20, 2022 |
| DEFA14A | Additional proxy material | Feb 3, 2022 | — |
| DEFA14A | Additional proxy material | Feb 1, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2021 | Jun 23, 2021 |
Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VREOF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Minneapolis, MN
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1771706
- Former names
- Goodness Growth Holdings, Inc. (until Jun 24, 2024); Vireo Health International, Inc. (until May 14, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.